ROIV
Roivant Sciences·NASDAQ
--
--(--)
--
--(--)
6.30 / 10
Outperform
Analyst coverage is robust and bullish—66.7% Strong Buy and 33.3% Buy from three institutions—supported by a 4.92 historical weighted rating. Fund-flow data register a 7.69/10 score with overall inflow ratio at 0.462, though trends are negative across block and size brackets. Together, the strong analyst conviction offsets modest capital-flow caution, reinforcing a neutral-to-bullish sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-15
InstitutionGoldman Sachs
Times predicted2
Historical Win Rate100.0%
Is money flowing into or out of ROIV?
- ROIV holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.30/10 (Outperform).
